D-015
Today
2025.04.30
2025.04.30
Program
Scientific Program
- May 15(Thu)
- 09:00-10:30
- KOR_Year in Review, Clinical
- Room 1 (3F)
- Korean (AI Translation)
- Chairs
- Shin-Seok Lee (Chonnam Nat'l Univ., Korea)
- Myeungsu Lee (Wonkwang Univ., Korea)
- 09:00-09:30
- Crystal arthropathy
- Yun Hong Cheon (Gyeongsang Nat'l Univ., Korea)
- 09:30-10:00
- Large vessel vasculitis
- Oh Chan Kwon (Yonsei Univ., Korea)
- 10:00-10:30
- IgG4-related disease
- Hyoun-ah Kim (Ajou Univ., Korea)
- May 15(Thu)
- 11:00-12:00
- Presidential Plenary Session
- Room 1 (3F)
- Korean (AI Translation)
- Chair
- Hoon-Suk Cha (Sungkyunkwan Univ., Korea)
- 11:00-11:30
- Innovating rheumatology: Bridging tradition and tomorrow
- Tae-Hwan Kim (Hanyang Univ., Korea)
- 11:30-12:00
- Navigating new frontiers in Korean rheumatology: A visionary's perspective
- Jung Soo Song (Chung-Ang Univ., Korea)
- May 15(Thu)
- 12:00-13:00
- Luncheon Symposium 1 [Johnson&Johnson]
- Advancing RA Care: Practical Insight of Golimumab IV
- Room 1 (3F)
- Korean (AI Translation)
- Chair
- Chang Keun Lee (Univ. of Ulsan, Korea)
- 12:00-13:00
- Optimizing RA care with Golimumab IV: Clinical impact from the first dose
- So-Young Bang (Hanyang Univ., Korea)
- May 15(Thu)
- 13:00-14:30
- International Symposium 1_Insights from the Editorial Board: Navigating the World of Publishing in Leading Medical Journals
- Room 1 (3F)
- ENG/KOR (AI Translation)
- Chairs
- Young Ho Lee (Korea Univ., Korea)
- Hae-Rim Kim (Konkuk Univ., Korea)
- 13:00-13:30
- Strategies for publishing in high impact journals: The Lancet Rheumatology
- Anna Clark (The Lancet Rheumatology, UK)
- 13:30-14:00
- The distinctiveness and mission of IJRD as a leading journal in the rheumatology of the Asian-Pacific region
- James Cheng-Chung Wei (Chung Shan Medical Univ., Taiwan)
- 14:00-14:30
- Future direction of Journal of Rheumatic Diseases
- Min-Chan Park (Yonsei Univ., Korea)
- May 15(Thu)
- 15:30-17:30
- International Joint Symposium (KCR and APLAR member)
- Room 1 (3F)
- English (AI Translation)
- Chairs
- Kichul Shin (Seoul Nat'l Univ., Korea)
- Lai-Shan Tam (The Chinese Univ. of Hong Kong, Hong Kong)
- 15:30-16:00
- Sjögren’s Syndrome: New world revealed by multi-omics analysis
- Tsutomu Takeuchi (Saitama Medical Univ., Japan)
- 16:00-16:30
- Optimal application MRI in axial spondyloarthritis harnessing AI
- Ashish Mathew (Christian Medical College Vellore, India)
- 16:30-17:00
- What’s new in Gout management?
- Nicola Dalbeth (Univ. of Auckland/Health New Zealand, New Zealand)
- 17:00-17:30
- Unseen burden: SLE in women of childbearing age
- Jisoo Lee (Ewha Womans Univ., Korea)
- May 15(Thu)
- 17:30-18:30
- Evening Symposium 1 [Eisai Korea Inc.]
- A Well-balanced JAKi for Patients with RA
- Room 1 (3F)
- Korean (AI Translation)
- Chair
- Bin Yoo (Univ. of Ulsan, Korea)
- 17:30-18:30
- Efficacy and safety of Jyseleca for the treatment of rheumatoid arthritis: Recent updates
- Doo-Ho Lim (Univ. of Ulsan, Korea)
- May 15(Thu)
- 08:00-09:00
- Breakfast Symposium 1 [Samsung Bioepis]
- Behçet Disease
- Room 2 (3F)
- Korean (AI Translation)
- Chair
- Sang-il Lee (Gyeongsang Nat'l Univ., Korea)
- 08:00-09:00
- Treatment options for Behçet's Disease: The emerging role of biologic therapies
- You-Jung Ha (Seoul Nat'l Univ., Korea)
- May 15(Thu)
- 12:00-13:00
- Luncheon Symposium 2 [Abbvie]
- Unlocking the Therapeutic Potential of JAK Inhibitors in Axial Spondyloarthritis Management
- Room 2 (3F)
- Korean (AI Translation)
- Chair
- Geun Tae Kim (Kosin Univ., Korea)
- 12:00-13:00
- Comprehensive management of axial spondyloarthritis with Upadacitinib
- Yun Hong Cheon (Gyeongsang Nat'l Univ., Korea)
- May 15(Thu)
- 13:00-14:30
- Free Paper Session 1_Systemic Lupus Erythematosus and Antiphospholipid Syndrome (I)
- Room 2 (3F)
- English (AI Translation)
- Chairs
- Jisoo Lee (Ewha Womans Univ., Korea)
- Chang-Hee Suh (Ajou Univ., Korea)
- 13:00-13:10
- Hypoalbuminemia as a risk factor for recurrent ascites in systemic lupus erythematosus
- Young Eun Kim (Univ. of Ulsan, Korea)
- 13:10-13:20
- Prognostic factors of pulmonary arterial hypertension in Korean patients with systemic lupus erythematosus diagnosed by right heart catheterization
- Ji-Hyoun Kang (Chonnam Nat'l Univ., Korea)
- 13:20-13:30
- Evaluating urinary acetylated proteins as biomarkers for lupus nephritis: A prospective cohort study
- Yeo-Jin Lee (Univ. of Ulsan, Korea)
- 13:30-13:40
- Effect of ultraviolet light exposure on disease activity in patients with systemic lupus erythematosus
- Sung Cheol Jung (Seoul Nat'l Univ., Korea)
- 13:40-13:50
- Early-onset of systemic lupus erythematosus associated with disease activity, clinical features in Malay patients: Preliminary findings from iLUPUS study
- Muhammad Fazrul Azim Abd halil (Ministry of Health Malaysia, Malaysia)
- 13:50-14:00
- Distinct gut microbiome and metabolome profiles in Korean systemic lupus erythematosus patients
- Youngjae Park (The Catholic Univ. of Korea, Korea)
- 14:00-14:10
- Gut microbiota-derived metabolite trimethylamine N-oxide in Korean patients with systemic lupus erythematosus
- Jiwon Yang (The Catholic Univ. of Korea, Korea)
- 14:10-14:20
- Validation of the newly developed definition of lupus low disease activity and its prognostic significance in patients with systemic lupus erythematosus
- Ji-Hyoun Kang (Chonnam Nat'l Univ., Korea)
- 14:20-14:30
- Longitudinal fluctuations of antiphospholipid antibodies and vascular events in a cohort of newly diagnosed systemic lupus erythematosus: A two year follow up study
- Ritesh Kumar Mishra (Jawaharlal Institute of Postgraduate Medical Education and Research, India)
- May 15(Thu)
- 15:30-16:30
- Free Paper Session 2_Systemic Lupus Erythematosus and Antiphospholipid Syndrome (II)
- Room 2 (3F)
- English (AI Translation)
- Chair
- Hye-Soon Lee (Hanyang Univ., Korea)
- 15:30-15:40
- TRIM6 increases the risk of systemic lupus erythematosus by reducing interleukin-10 levels: A multiomics mediation mendelian randomization analysis
- Lei Chen (Sichuan Univ., China)
- 15:40-15:50
- Identification of plasma causal proteins related to macrophage activation in systemic lupus erythematosus via multi-omics analysis
- Manrong He (Sichuan Univ., China)
- 15:50-16:00
- Suppression of CXCL10 via progesterone-induced blocking factor 1 in the systemic lupus erythematosus
- Young Eun Kim (Univ. of Ulsan, Korea)
- 16:00-16:10
- Novel STAT3 inhibitor exhibits therapeutic potential in murine lupus
- Wook-Young Baek (Ajou Univ., Korea)
- 16:10-16:20
- CD10high low-density granulocytes is a potential marker of disease activity in antiphospholipid syndrome
- Xiaocong Huo (Peking Univ., China)
- 16:20-16:30
- Allopurinol attenuates lupus disease activity by lowering uric acid levels in MRL/lpr mice
- Yeo-Jin Lee (Univ. of Ulsan, Korea)
- May 15(Thu)
- 16:30-17:30
- Free Paper Session 4_Sjögren's Syndrome
- Room 2 (3F)
- English (AI Translation)
- Chair
- Seung-Ki Kwok (The Catholic Univ. of Korea, Korea)
- 16:30-16:40
- Effectiveness of glucocorticoid in Sjögren’s syndrome: A real-world cohort study
- Xiangpeng Wang (Peking Union Medical College Hosp., China)
- 16:40-16:50
- Minimally invasive, rapid, and safe method for minor salivary gland biopsy using a chalazion clamp and a needle
- Ki-Jeong Park (Chonnam Nat'l Univ., Korea)
- 16:50-17:00
- Antagonist of sphingosine 1-phosphate ameliorates Sjögren's syndrome by reciprocal regulation of germinal center B cells and Breg cells
- JeongWon Choi (The Catholic Univ. of Korea, Korea)
- 17:00-17:10
- Clinical implications of expression of costimulatory molecules in Sjögren's syndrome
- Youngjae Park (The Catholic Univ. of Korea, Korea)
- May 15(Thu)
- 17:30-18:30
- Evening Symposium 2 [Astellas]
- Innovations in Lupus Nephritis Management
- Room 2 (3F)
- English (AI Translation)
- Chair
- Jung-Yoon Choe (Daegu Catholic Univ., Korea)
- 17:30-18:30
- Role of calcineurin inhibitors in the current therapeutic landscape for lupus nephritis
- Tak Mao Chan (The Univ. of Hong Kong, Hong Kong)
- May 15(Thu)
- 09:00-10:30
- KOR_Year in Review, Basic
- Room 3 (5F)
- Korean (AI Translation)
- Chairs
- Wan-Uk Kim (The Catholic Univ. of Korea, Korea)
- Eon Jeong Nam (Kyungpook Nat'l Univ., Korea)
- 09:00-09:30
- Recent advances in basic research on SLE
- Seokchan Hong (Univ. of Ulsan, Korea)
- 09:30-10:00
- Recent advances in basic research on RA
- Seungwoo Han (Kyungpook Nat'l Univ., Korea)
- 10:00-10:30
- Advances in Systemic Sclerosis: Emerging pathogenic insights and breakthroughs in basic research
- Su-Jin Moon (The Catholic Univ. of Korea, Korea)
- May 15(Thu)
- 12:00-13:00
- Luncheon Symposium 3 [Pfizer & Hanlim MS]
- Beyond 10 Years Experienced JAK-i in RA, Tofacitinib
- Room 3 (5F)
- Korean (AI Translation)
- Chair
- Yun Jong Lee (Seoul Nat'l Univ., Korea)
- 12:00-13:00
- Long term strategy for the treatment of patients with RA
- Seokchan Hong (Univ. of Ulsan, Korea)
- May 15(Thu)
- 13:00-14:30
- KCR-KASID Joint Symposium
- Room 3 (5F)
- English (AI Translation)
- Chairs
- Seong Ryul Kwon (Inha Univ., Korea)
- Sung-Ae Jung (Ewha Womans Univ., Korea)
- 13:00-13:30
- Connections between spondyloarthritis and IBD: The immunobiology link
- Tae-Jong Kim (Chonnam Nat'l Univ., Korea)
- 13:30-14:00
- GI involvement of Behcet's disease: Another subset of IBD
- Jae Hee Cheon (Yonsei Univ., Korea)
- 14:00-14:30
- New aspects of IBD treatment: From cytokines to small molecules
- Sung Noh Hong (Sungkyunkwan Univ., Korea)
- May 15(Thu)
- 15:30-16:30
- Free Paper Session 3_Muscle Disease Including Myopathies
- Room 3 (5F)
- English (AI Translation)
- Chair
- Jinhyun Kim (Chungnam Nat'l Univ., Korea)
- 15:30-15:40
- Anti-mitochondrial M2 antibody is associated with cardiac involvements and immune-mediate necrotizing myopathy in idiopathic inflammatory myopathies: A long-term retrospective cohort study
- Yiyun Pang (Peking Union Medical College, China)
- 15:40-15:50
- Disease trajectory in anti-MDA5 dermatomyositis patients presented with different stages of interstitial lung disease
- Ting-Yuan Lan (Nat'l Taiwan Univ., Taiwan)
- 15:50-16:00
- Cardio-Pulmonary Exercise Rest (CPET) performance and the factors associated with it in patients with Idiopathic Inflammatory Myopathies (IIM)
- Lovely Kumari (Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), India)
- 16:00-16:10
- Transcriptomic analysis of muscle tissue shows increased myogenesis and a distinct macrophage population in idiopathic inflammatory myopathy
- Seon Uk Kim (Seoul Nat'l Univ., Korea)
- 16:10-16:20
- Type 1 interferon signature and B lymphocyte subsets in juvenile dermatomyositis: Correlations with clinical parameters and disease activity
- Aditya Dod (Post Graduate Institute of Medical Education and Research, India)
- 16:20-16:30
- Mitochondrial transplantation as a novel therapeutic approach in idiopathic inflammatory myopathy
- Eun Young Lee (Seoul Nat'l Univ., Korea)
- May 15(Thu)
- 16:30-17:30
- Free Paper Session 5_Vasculitis, Systemic Sclerosis and Fibromyalgia
- Room 3 (5F)
- English (AI Translation)
- Chair
- Sang-Won Lee (Yonsei Univ., Korea)
- 16:30-16:40
- Outcomes of Kawasaki disease in children with spontaneous defervescence- our experience at Chandigarh, North India
- Yamini Sharma (Post Graduate Institute of Medical Education and Research (PGIMER), India)
- 16:40-16:50
- Kawasaki disease, immunodeficiency and pediatric unrelated conditions: The pediatrician’s conundrum
- Radhika Semwal (Post Graduate Institute of Medical Education and Research (PGIMER), India)
- 16:50-17:00
- Ferroptosis inhibition alleviates fibrosis in murine models of systemic sclerosis
- Su-Jin Moon (The Catholic Univ. of Korea, Korea)
- 17:00-17:10
- Association of serum homocysteine, folic acid, and vitamin B12 levels in juvenile fibromyalgia patientsv
- Pardeep Kumar (F H Medical College & Hosp., India)
- May 15(Thu)
- 17:30-18:30
- Evening Symposium 3 [Lilly]
- Optimizing Axial Spondyloarthritis Management
- Room 3 (5F)
- English (AI Translation)
- Chair
- Tae-Hwan Kim (Hanyang Univ., Korea)
- 17:30-18:30
- Treating patients with different CRP level
- Raj Sengupta (The Royal Nat'l Hosp. for Rheumatic Diseases, Bath, UK)
- May 16(Fri)
- 08:00-09:00
- Breakfast Symposium 2 [Abbvie]
- Unlocking the Therapeutic Potential of JAK Inhibitors in Rheumatoid Arthritis Management
- Room 1 (3F)
- Korean (AI Translation)
- Chair
- Sang-Heon Lee (Konkuk Univ., Korea)
- 08:00-09:00
- Persistence of remission in rheumatoid arthritis with Upadacitinib
- Yeon-Ah Lee (Kyung Hee Univ., Korea)
- May 16(Fri)
- 09:00-10:00
- Keynote Lecture 1
- Room 1 (3F)
- English (AI Translation)
- Chair
- Seung Cheol Shim (Chungnam Nat'l Univ., Korea)
- 09:00-10:00
- Multi-omics approach in rheumatology: From cells to precision medicine
- Keishi Fujio (The Univ. of Tokyo, Japan)
- May 16(Fri)
- 10:30-12:00
- International Symposium 2_Innovative Therapeutic Strategies in Axial Spondyloarthritis
- Room 1 (3F)
- English (AI Translation)
- Chairs
- Tae-Hwan Kim (Hanyang Univ., Korea)
- Tae-Jong Kim (Chonnam Nat'l Univ., )
- 10:30-11:00
- Tailored therapeutic approaches for biologics and JAK inhibitors in axial spondyloarthritis
- Lianne S. Gensler (Univ. of California, San Francisco, USA)
- 11:00-11:30
- Exploring the intestinal microbiome in axial spondyloarthritis
- Francesco Ciccia (Univ. della Campania L. Vanvitelli, Italy)
- 11:30-12:00
- Optimizing biologic tapering strategies in spondyloarthritis
- Hong Ki Min (Konkuk Univ., Korea)
- May 16(Fri)
- 12:00-13:00
- Luncheon Symposium 4 [Samsung Bioepis]
- Bone Disease
- Room 1 (3F)
- Korean (AI Translation)
- Chair
- Jung Soo Song (Chung-Ang Univ., Korea)
- 12:00-13:00
- The changing landscape of bone disease management & clinical insight of Denosumab biosimilar
- Jinwuk Hur (Eulji Univ., Korea)
- May 16(Fri)
- 13:00-14:30
- International Symposium 3_Geriatrics in Rheumatology: How to Optimize the Treatment for Aging Patients
- Room 1 (3F)
- English (AI Translation)
- Chairs
- Sang-Cheol Bae (Hanyang Univ., Korea)
- Hyun-Sook Kim (Soonchunhyang Univ., Korea)
- 13:00-13:30
- The immune system's twilight: Immunosenescence and inflammaging as interconnected phenomena
- Won-Woo Lee (Seoul Nat'l Univ., Korea)
- 13:30-14:00
- Essential considerations for treating older rheumatology patients
- Una Makris (UT Southwestern Medical Center, USA)
- 14:00-14:30
- Polymyalgia rheumatica: Not an isolated disease but rather a disease spectrum
- Milena Bond (Hosp. of Brunico, Italy)
- May 16(Fri)
- 15:30-17:00
- International Symposium 4_Optimizing Treatment Strategies to Mitigate Cardiovascular Risk in Rheumatoid Arthritis Patients
- Room 1 (3F)
- English (AI Translation)
- Chairs
- Jung-Yoon Choe (Daegu Catholic Univ., Korea)
- Yoon-Kyoung Sung (Hanyang Univ., Korea)
- 15:30-16:00
- Impact of disease-modifying anti-rheumatic drugs on vascular inflammation in rheumatoid arthritis patients
- Joan M Bathon (Columbia Univ., USA)
- 16:00-16:30
- Treatment approaches for elderly rheumatoid arthritis patients in Japan: A focus on cardiovascular health
- Toshihiro Nanki (Toho Univ., Japan)
- 16:30-17:00
- Current evidence on JAK inhibitors and cardiovascular risk in Korean rheumatoid arthritis patients
- Soo-Kyung Cho (Hanyang Univ., Korea)
- May 16(Fri)
- 08:00-09:00
- Breakfast Symposium 3 [Celltrion]
- Efficacy of Infliximab SC in Treatment of axSpA
- Room 2 (3F)
- Korean (AI Translation)
- Chair
- Chang-Hee Suh (Ajou Univ., Korea)
- 08:00-09:00
- Real-world evidence of IFX SC in treatment of axSpA
- Sang-Hoon Lee (Kyung Hee Univ., Korea)
- May 16(Fri)
- 10:30-12:00
- Free Paper Session 6_Rheumatoid Arthritis (I)
- Room 2 (3F)
- English (AI Translation)
- Chairs
- Jinseok Kim (Jeju Nat'l Univ., Korea)
- Sung Won Lee (Dong-A Univ., Korea)
- 10:30-10:40
- Clinical characteristics and management for flares in patients with rheumatoid arthritis treated with biologic and targeted synthetic disease-modifying antirheumatic drugs: Results from the KOBIO registry
- Young Eun Kim (Univ. of Ulsan, Korea)
- 10:40-10:50
- Outcomes of tapering biologic and targeted synthetic disease modifying antirheumatic drugs in rheumatoid arthritis: A multicenter randomized non-inferiority trial
- Sung-Eun Choi (Chonnam Nat'l Univ., Korea)
- 10:50-11:00
- Impact of disease duration on quality-of-life outcomes in rheumatoid arthritis receiving biologic DMARDs or JAK inhibitors
- Se Rim Choi (Hanyang Univ., Korea)
- 11:00-11:10
- Investigating the impact of biological and targeted synthetic disease-modifying anti-rheumatic drugs on rheumatoid arthritis: insights from mendelian randomization
- Mihye Kwon (Konyang Univ. Hosp., Korea)
- 11:10-11:20
- APOA2 and dyslipidemia: Potential predictors of rheumatoid arthritis-associated interstitial lung disease
- Eunji Jeong (Kyung Hee Univ., Korea)
- 11:20-11:30
- Risk stratification in rheumatoid arthritis-associated interstitial lung disease: A novel prediction model incorporating biomarkers
- Sung Hae Chang (Soonchunhyang Univ., Korea)
- 11:30-11:40
- Exploring potential drugs with dual anti-rheumatic and anti-fibrotic efficacy for rheumatoid arthritis-associated interstitial lung disease
- Misong Kim (Kyung Hee Univ., Korea)
- 11:40-11:50
- Clinical outcome of lung transplantation in patients with connective tissue disease-related interstitial lung disease: A retrospective cohort study
- Ju Yeon Kim (Chung-Ang Univ., Korea)
- May 16(Fri)
- 12:00-13:00
- Luncheon Symposium 5 [Eisai Korea Inc.]
- A Well-balanced JAKi for Patients with RA
- Room 2 (3F)
- English (AI Translation)
- Chair
- Ji Hyeon Ju (The Catholic Univ. of Korea, Korea)
- 12:00-13:00
- The role of Jyseleca in rheumatoid arthritis: Insights from the Japanese experience
- Tomohiro Koga (Nagasaki Univ., Japan)
- May 16(Fri)
- 13:00-14:30
- Free Paper Session 8_Rheumatoid Arthritis (II)
- Room 2 (3F)
- English (AI Translation)
- Chairs
- Young Mo Kang (Kyungpook Nat'l Univ., Korea)
- Chan Hong Jeon (Soonchunhyang Univ., Korea)
- 13:00-13:10
- Saliva-based proteomic profiling to identify biomarkers for seronegative rheumatoid arthritis
- Eunji Jeong (Kyung Hee Univ., Korea)
- 13:10-13:20
- Mitochondrial transplantation ameliorates rheumatoid arthritis by targeting abnormal CGAS-STING1 signaling activation, autophagosome accumulation, and necroptosis
- Aram Lee (The Catholic Univ. of Korea, Korea)
- 13:20-13:30
- MtSTAT3 suppresses rheumatoid arthritis by regulating Th17 and synovial fibroblast inflammatory cell death with IL-17-mediated autophagy dysfunction
- Seon-Yeong Lee (The Catholic Univ. of Korea, Korea)
- 13:30-13:40
- Tacrolimus reduced cell viability of rheumatoid arthritis fibroblast-like synoviocytes through inhibition of autophagy flux
- Kyung Me Kim (Eulji Univ., Korea)
- 13:40-13:50
- Bifidobacterium longum BFD1R alleviates rheumatoid arthritis by modulating TDCA to inhibit IL-17 production and osteoclast differentiation
- JooYeon Jhun (The Catholic Univ. of Korea, Korea)
- 13:50-14:00
- The detrimental effects of intra-articular injections of umbilical cord blood-derived mesenchymal stem cells on pannus invasiveness
- Sungeun Kim (Seoul Nat'l Univ., Korea)
- 14:00-14:10
- AI-driven integration of single-cell transcriptomics and spatial immune modeling to predict treatment resistance in rheumatoid arthritis
- Prihantini Prihantini (The Integrated Mathematical, Computational, and Data Science for BioMedicine Research Foundation, Indonesia)
- 14:10-14:20
- Predicting side effects of methotrexate mono- or combination therapy in patients with rheumatoid arthritis using explainable machine learning: A nationwide multicenter cohort study
- Ki Won Moon (Kangwon Nat'l Univ., Korea)
- 14:20-14:30
- Pentagalloylglucose as a novel inhibitor of the cGAS-STING pathway for the treatment of rheumatoid arthritis
- Congyang Zheng (The Second Medical Center of Chinese PLA General Hosp., China)
- May 16(Fri)
- 15:30-16:30
- Free Paper Session 9_Rheumatoid Arthritis (III)
- Room 2 (3F)
- English (AI Translation)
- Chairs
- Hyun Ah Kim (Hallym Univ., Korea)
- Jaejoon Lee (Sungkyunkwan Univ., Korea)
- 15:30-15:40
- Association between rheumatoid arthritis and carotid atherosclerotic plaques in the elderly
- Ngoc Son Dang (Univ. Medical Center HCMC, Vietnam)
- 15:40-15:50
- Longitudinal study on the impact of inflammatory markers and lipid changes on cardiovascular events in rheumatoid arthritis patients: A 17-year follow-up
- Somin Lee (Kyunghee University, Korea)
- 15:50-16:00
- High dose folic acid supplement is associated with increased cardiovascular risk in rheumatoid arthritis patients on methotrexate
- Huan Meng (The Chinese Univ. of Hong Kong, China)
- 16:00-16:10
- Baseline mood status and biologic and targeted synthetic disease modifying antirheumatic drugs survival in rheumatoid arthritis: Insights from the Korean biologics registry
- Deok Yeong Gwon (Yonsei Univ., Korea)
- 16:10-16:20
- Early rheumatoid arthritis: Two distinctive structural damage patterns revealed by MRI, an 8-year longitudinal study
- Su Wu (The Chinese Univ. of Hong Kong, Hong Kong)
- 16:20-16:30
- Effects of achieving SDAI remission on joint space outcomes progression in early rheumatoid arthritis: An HR-pQCT study
- Qihan Wu (The Chinese Univ. of Hong Kong, Hong Kong)
- May 16(Fri)
- 16:30-17:30
- Free Paper Session 10_Spondyloarthropathy Including Psoriatic Arthritis (II)
- Room 2 (3F)
- English (AI Translation)
- Chair
- Seong-Kyu Kim (Daegu Catholic Univ., Korea)
- 16:30-16:40
- Single-cell RNA sequencing reveals the critical role of innate immunity in identifying candidates for early biologics treatment in axial spondyloarthritis
- Seulkee Lee (Sungkyunkwan Univ., Korea)
- 16:40-16:50
- PPM1A deficiency in macrophages increases IL-1β secretion in ankylosing spondylitis
- Yeo-Jin Lee (Univ. of Ulsan, Korea)
- 16:50-17:00
- Allograft inflammatory factor 1, induced by activated monocytes, promotes the polarization of Th17 and Th1 cell in spondyloarthritis
- Seo Yoon Ban (Seoul Nat'l Univ., Korea)
- 17:00-17:10
- Osteoclast-derived Del-1 exacerbates bone formation in ankylosing spondylitis
- Seung Hoon Lee (Hanyang Univ., Korea)
- 17:10-17:20
- Evaluating the anti-inflammatory and therapeutic potential of tacrolimus in ankylosing spondylitis: Insights from human and murine models
- Sooin Park (Chonnam Nat'l Univ., Korea)
- May 16(Fri)
- 08:00-09:00
- Breakfast Symposium 4 [Daewoong]
- Realizing the True Value of Biosimilars
- Room 3 (5F)
- Korean (AI Translation)
- Chair
- Seung-Jae Hong (Kyung Hee Univ., Korea)
- 08:00-09:00
- New era of Biosimilar in rheumatic diseases
- Eun Hye Park (Chung-Ang Univ., Korea)
- May 16(Fri)
- 10:30-12:00
- KCR-KSID Joint Symposium
- Room 3 (5F)
- English (AI Translation)
- Chairs
- Eun Bong Lee (Seoul Nat'l Univ., Korea)
- Sang Oh Lee (Univ. of Ulsan, Korea)
- 10:30-11:00
- Immune dysregulation and long COVID
- Sung-Han Kim (Univ. of Ulsan, Korea)
- 11:00-11:30
- Post-COVID19 autoimmune diseases; Myth or reality
- Jaehun Jung (Korea Univ., Korea)
- 11:30-12:00
- How to optimize vaccine response in patients with rheumatic diseases
- Jin Kyun Park (Seoul Nat'l Univ., Korea)
- May 16(Fri)
- 12:00-13:00
- Luncheon Symposium 6 [Novartis]
- Spotlight Secukinumab in Axial Spondyloarthritis
- Room 3 (5F)
- English (AI Translation)
- Chair
- Yong-Beom Park (Yonsei Univ., Korea)
- 12:00-13:00
- Secukinumab in axial spondyloarthritis: Advancing IL-17 inhibition for better patient outcomes
- Lianne S. Gensler (Univ. of California, San Francisco, USA)
- May 16(Fri)
- 13:00-14:30
- Free Paper Session 7_Spondyloarthropathy Including Psoriatic Arthritis (I)
- Room 3 (5F)
- English (AI Translation)
- Chairs
- Chan-Bum Choi (Hanyang Univ., Korea)
- Seonghoon Park (Daegu Catholic Univ., Korea)
- 13:00-13:10
- Nationwide specialty-based analysis of TNF inhibitor rse and retention in axial spondyloarthritis using national health insurance data
- Bon San Koo (Inje Univ., Korea)
- 13:10-13:20
- Persistence of second-line targeted therapies after TNF-α inhibitor use in ankylosing spondylitis
- Yu-Seon Jung (Hanyang Univ., Korea)
- 13:20-13:30
- Retention rate of TNF inhibitors versus IL-17 inhibitors in ankylosing spondylitis patients with prior biologics experience
- Jiwon Yang (The Catholic Univ. of Korea, Korea)
- 13:30-13:40
- Long-term non-steroidal anti-inflammatory drug use and renal function changes in patients with ankylosing spondylitis: A real-world evidence with meta-analysis from two centers
- Young Eun Kim (Univ. of Ulsan, Korea)
- 13:40-13:50
- Alteration of gut microbiome in ankylosing spondylitis and its association with disease activity
- Hyemin Jeong (Soonchunhyang Univ., Korea)
- 13:50-14:00
- Vascular effects of achieving low disease activity in axial spondylarthritis - a 2-year prospective cohort study
- Huan Meng (The Chinese Univ. of Hong Kong, China)
- 14:00-14:10
- Association of the driving distance, driving time, and public transit time to the hospital with the persistence of tumor necrosis factor inhibitors in patients with ankylosing spondylitis
- Seung-Geun Lee (Pusan Nat'l Univ., Korea)
- 14:10-14:20
- Artificial intelligence in axial spondyloarthritis diagnosis: Integrating structural and inflammatory lesions from sacrum MRI
- Seulkee Lee (Sungkyunkwan Univ., Korea)
- 14:20-14:30
- Reliability and validity of the Korean translation of the PSAID questionnaire
- Bon San Koo (Inje Univ., Korea)
- May 16(Fri)
- 15:30-17:30
- KOR_Health Insurance Committee Session_The Process for Insurance Coverage of Medical Procedures and Medications in the Rheumatology Field
- Room 3 (5F)
- Korean (AI Translation)
- Chairs
- Hoon-Suk Cha (Sungkyunkwan Univ., Korea)
- Chong-Hyeon Yoon (The Catholic Univ. of Korea, Korea)
- 15:30-16:00
- The process for insurance coverage of medical procedures
- Seong-hun Jeong (Ministry of Health and Welfare, Division of Health Insurance Benefits, Korea)
- 16:00-16:30
- The process of insurance coverage for medications and unmet needs in rheumatology field
- Bo Young Yoon (Inje Univ., Korea)
- 16:30-17:30
- Panel Discussion
- May 17(Sat)
- 08:00-09:00
- Breakfast Symposium 5 [Novartis]
- Revolutionizing Autoimmune Therapy
- Room 1 (3F)
- English (AI Translation)
- Chair
- Shin-Seok Lee (Chonnam Nat'l Univ., Korea)
- 08:00-09:00
- B cells at the core: Unlocking new insights in autoimmune disease
- Peter Gergely (Novartis Biomedical Research, Switzerland)
- May 17(Sat)
- 09:00-10:00
- Keynote Lecture 2
- Room 1 (3F)
- English (AI Translation)
- Chair
- Jung Soo Song (Chung-Ang Univ., Korea)
- 09:00-10:00
- Cell therapy in rheumatic diseases
- Ji Hyeon Ju (The Catholic Univ. of Korea, Korea)
- May 17(Sat)
- 10:30-12:00
- Free Paper Session 11_Epidemiology & Public Health
- Room 1 (3F)
- English (AI Translation)
- Chairs
- Sang-Heon Lee (Konkuk Univ., Korea)
- Jin Kyun Park (Seoul Nat'l Univ., Korea)
- 10:30-10:40
- Sex differences in treatment response to targeted therapy in rheumatoid arthritis: A post hoc analysis of a prospective cohort study
- Se Rim Choi (Hanyang Univ., Korea)
- 10:40-10:50
- A comparative study on the prevalence and mortality of rheumatoid arthritis across sociodemographic indexes in 2021
- Salma Humairah (Educational Univ. of Indonesia, Indonesia)
- 10:50-11:00
- Cervical cancer screening rates among Korean women of childbearing age with systemic lupus erythematosus
- Jinsu Park (Nat'l Health Insurance Service Ilsan Hosp., Korea)
- 11:00-11:10
- Cancer risk in patients with systemic lupus erythematosus: A population-based cohort study in Korea 2004–2021
- Su Jin Choi (Univ. of Ulsan, Korea)
- 11:10-11:20
- Trends in prevalence and drug utilization of ankylosing spondylitis in Korea (2010–2023): Insights from a nationwide study
- Yu-Seon Jung (Hanyang Univ., Korea)
- 11:20-11:30
- Evaluating antinuclear antibody positivity in dermatology patients to detect underlying rheumatic diseases
- Yunjung Choi (Jeonbuk Nat'l Univ., Korea)
- 11:30-11:40
- Study on the mechanism of pain improvement in rheumatic and autoimmune disease patients based on human factors engineering: A multi-center cohort study
- Ji Luo (People’s Hosp. of Chongqing Banan District, China)
- 11:40-11:50
- Musculoskeletal disorders in women of childbearing age: Global trends, socio-demographic disparities, and future projections
- Liang Luo (Hunan Univ., China)
- May 17(Sat)
- 12:00-13:00
- Luncheon Symposium 7 [Celltrion]
- Tocilizumab Biosimilar for Rheumatoid Arthritis
- Room 1 (3F)
- English (AI Translation)
- Chair
- Seung Cheol Shim (Chungnam Nat'l Univ., Korea)
- 12:00-13:00
- CT-P47(Avtozma) clinical trial review based on efficacy and safety
- Josef S. Smolen (Medical Univ. of Vienna, Austria)
- May 17(Sat)
- 13:00-14:30
- Free Paper Session 14_Osteoarthritis, Low Back Pain, and Miscellaneous
- Room 1 (3F)
- English (AI Translation)
- Chairs
- Gunwoo Kim (Daegu Fatima Hosp., Korea)
- Hyun Sik Gong (Seoul Nat'l Univ., Korea)
- 13:00-13:10
- Genetic variation of the vitamin D binding protein in carpal tunnel syndrome patients affects their response to vitamin D supplementation
- Ji Sup Hwang (Seoul Nat'l Univ., Korea)
- 13:10-13:20
- A ROS-responsive hydrogel with PdH nanoparticles for hydrogen therapy, photothermal lubrication, and senescence suppression in osteoarthritis treatment
- Tianqi Wang (Nat'l Univ. of Singapore, Singapore)
- 13:20-13:30
- Adenosine and guanosine-based oligonucleotide attenuates catabolic phenotypes in chondrocytes and slows progression of surgically induced osteoarthritis
- Yoonhee Kim (Kyungpook Nat'l Univ., Korea)
- 13:30-13:40
- Patient-specific design and fabrication of a trapeziometacarpal joint orthosis using a computed tomography image-based finite element model
- Ji Sup Hwang (Seoul Nat'l Univ., Korea)
- 13:40-13:50
- Association between tooth loss and radiographic progression of hand osteoarthritis: Findings from a 6-year longitudinal cohort study
- Sung-Eun Choi (Chonnam Nat'l Univ., Korea)
- 13:50-14:00
- Efficacy of tamoxifen in the treatment of idiopathic retroperitoneal fibrosis: A retrospective comparable cohort study
- Ruichan Si (Peking Univ., China)
- 14:00-14:10
- Temporal AI-driven multi-omics framework for predicting personalized flare dynamics in systemic autoimmune rheumatic diseases
- Rifaldy Fajar (The Integrated Mathematical, Computational, and Data Science for BioMedicine Research Foundation, Indonesia)
- May 17(Sat)
- 08:00-09:00
- Breakfast Symposium 6 [Johnson&Johnson]
- Durable AS Treatment Option, Golimumab
- Room 2 (3F)
- Korean (AI Translation)
- Chair
- Sung Hwan Park (The Catholic Univ. of Korea, Korea)
- 08:00-09:00
- How Golimumab shapes the future of AS patients with “Persistence”
- Seulkee Lee (Sungkyunkwan Univ., Korea)
- May 17(Sat)
- 10:30-12:00
- Free Paper Session 12_Basic Research
- Room 2 (3F)
- English (AI Translation)
- Chairs
- Seungwoo Han (Kyungpook Nat'l Univ., Korea)
- Mi-La Cho (The Catholic Univ. of Korea, Korea)
- 10:30-10:40
- MicroRNA-Seq analysis reveals distinct miRNA expression in juvenile and adult systemic sclerosis
- Sanghamitra Machhua (Postgraduate Institute of Medical Education and Research (PGIMER), India)
- 10:40-10:50
- GM-CSF-induced CD16+ macrophages in patients with systemic sclerosis associated interstitial lung disease promote fibroblast activation through TREM2-mediated mechanisms
- Sang Jin Lee (Kyungpook Nat'l Univ., Korea)
- 10:50-11:00
- Exosomes from adult-onset still's disease patients drive macrophage polarization and amplify inflammatory responses
- Mi-Hyun Ahn (Ajou Univ., Korea)
- 11:00-11:10
- TIGIT and SLAMF7 double-positive Tfh2 cells activate naive B cells, leading to the generation of IgG4 producing memory B cells in IgG4 related disease
- MinGang Kim (Seoul Nat'l Univ., Korea)
- 11:10-11:20
- Shared and distinct features of the gut microbiome in immune-mediated inflammatory diseases: Initial analysis from the INTEGRATE cohort study
- Hyun Sik Kim (Kyung Hee Univ., Korea)
- 11:20-11:30
- Cigarette smoke extract promotes joint destruction and ectopic bone formation in curdlan-injected SKG mice through DNA damage and NF-κB signaling pathway
- Chanhyeok Jeon (Hanyang Univ., Korea)
- 11:30-11:40
- Soluble CCR2-expressing mesenchymal stem cells inhibit osteoarthritis development and progression
- Hyun Sik Na (The Catholic Univ. of Korea, Korea)
- 11:40-11:50
- Naringin mediated silver nanoparticles attenuate rheumatoid arthritis in mice by modulation of autophagy and PI3K/AKT/mTOR signaling pathway
- Ekta Yadav (Sam Higginbottom Univ. of Agriculture Technology and Sciences, India)
- May 17(Sat)
- 12:00-13:00
- Luncheon Symposium 8 [Boehringer Ingelheim]
- Present and Future Perspectives on CTD-ILD Management
- Room 2 (3F)
- English (AI Translation)
- Chair
- Eun Young Lee (Seoul Nat'l Univ., Korea)
- 12:00-13:00
- Guidelines for SARD-ILD and the treatment role of antifibrotic agent
- Oliver Distler (Univ. Hosp. Zurich, Switzerland)
- May 17(Sat)
- 13:00-14:30
- KOR_General Practitioners' Session
- Room 2 (3F)
- Korean (AI Translation)
- Chairs
- Dae Hyun Yoo (Yoo & Na Rheumatology Clinic, Korea)
- YoungOk Jung (Jung's Rheumatism Clinic, Korea)
- 13:00-13:30
- Learn about cardiac arrhythmias associated with rheumatic diseases
- Jae-Sun Uhm (Yonsei Univ., Korea)
- 13:30-14:00
- Stepwise approach to cytopenia - differential diagnosis with SLE
- Young Hoon Park (Ewha Womans Univ., Korea)
- 14:00-14:30
- Screening for interstitial lung disease in the general practice
- Yeon-Ah Lee (Kyung Hee Univ., Korea)
- May 17(Sat)
- 08:00-09:00
- Breakfast Symposium 7 [ChongKunDang & Amgen]
- Advancing Osteoporosis Care in Rheumatology Patients
- Room 3 (5F)
- Korean (AI Translation)
- Chair
- Yoon-Kyoung Sung (Hanyang Univ., Korea)
- 08:00-09:00
- Why Prolia? Emphasizing its originality in preventing fractures
- Sung Soo Kim (Univ. of Ulsan, Korea)
- May 17(Sat)
- 10:30-12:00
- Free Paper Session 13_Crystal Arthropathies
- Room 3 (5F)
- English (AI Translation)
- Chairs
- Seung-Jae Hong (Kyung Hee Univ., Korea)
- Jiseon Oh (Univ. of Ulsan, Korea)
- 10:30-10:40
- Sex differences in Korean patients with gout: A prospective, multicenter, observational study
- You-Jung Ha (Seoul Nat'l Univ., Korea)
- 10:40-10:50
- Establishing a prediction model of gout in patients with asymptomatic hyperuricemia based on a common data model plus machine learning algorithms
- Min Jung Kim (Seoul Nat'l Univ., Korea)
- 10:50-11:00
- Association between serum uric acid & abdominal fat distribution quantified by computed tomography in Korean men: A single center study
- Minsu Han (Univ. of Ulsan, Korea)
- 11:00-11:10
- The effect of uric acid lowering therapy on vascular stiffness in patients with gout
- Wooseong Jeong (Jeju Nat'l Univ., Korea)
- 11:10-11:20
- Increased cardiovascular risk in young patients with gout: A nationwide cohort study
- Yeonghee Eun (Sungkyunkwan Univ., Korea)
- 11:20-11:30
- NK cells are numerically reduced but functionally activated by the MSU crystal in gout
- Ki-Jeong Park (Chonnam Nat'l Univ., Korea)
- 11:30-11:40
- Analysis of the role of ABCG2 in kidney cell activation by monosodium urate (MSU) crystals through transfection of a specific sgRNA using the CRISPR-Cas9 technique
- Ambar López Macay (Instituto Nacional de Rehabilitación, Mexico)
- 11:40-11:50
- Reverse translational biomarker bifidobacterium as therapeutic candidate for gout treatment
- Mohammed Solayman Hossain (Soonchunhyang Univ., Korea)
- 11:50-12:00
- Auranofin alleviates gout inflammation by suppressing migration of neutrophil via IL-33/ST2 dependent pathway
- Hyeyeon Yoo (The Catholic Univ. of Korea, Korea)
- May 17(Sat)
- 12:00-13:00
- Luncheon Symposium 9 [JW Pharmaceutical]
- Tocilizumab: Treatment of Rheumatic Diseases
- Room 3 (5F)
- Korean (AI Translation)
- Chair
- Seong-Ho Kim (Inje Univ., Korea)
- 12:00-13:00
- The role of Tocilizumab in RA and JIA treatment
- Jennifer Jooha Lee (The Catholic Univ. of Korea, Korea)
- May 17(Sat)
- 13:00-14:30
- KCR-KCPCI Joint Symposium_Adult and Pediatric Rheumatic Diseases
- Room 3 (5F)
- English (AI Translation)
- Chairs
- Yong-wook Park (Chonnam Nat'l Univ., Korea)
- Youngdae Kim (Inje Univ., Korea)
- 13:00-13:30
- Treatment Patterns in Juvenile Idiopathic Arthritis in Korea
- Dae-Chul Jeong (The Catholic Univ. of Korea, Korea)
- 13:30-14:00
- Role of inflammatory cytokines and cytokine-targeted therapy in systemic JIA and MAS
- Masaki Shimizu (Institute of Science Tokyo, Japan)
- 14:00-14:30
- bDMARDs and tsDMARDs for adult and pediatric rheumatic diseases
- Su-Jin Moon (The Catholic Univ. of Korea, Korea)
